Cannara Biotech (TSXV:LOVE) Long-Term Debt : C$32.68 Mil (As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Long-Term Debt?

Cannara Biotech's Long-Term Debt for the quarter that ended in Nov. 2024 was C$32.68 Mil.

Cannara Biotech's quarterly Long-Term Debt declined from May. 2024 (C$38.95 Mil) to Aug. 2024 (C$38.45 Mil) and declined from Aug. 2024 (C$38.45 Mil) to Nov. 2024 (C$32.68 Mil).

Cannara Biotech's annual Long-Term Debt declined from Aug. 2022 (C$46.19 Mil) to Aug. 2023 (C$39.64 Mil) and declined from Aug. 2023 (C$39.64 Mil) to Aug. 2024 (C$38.45 Mil).

Cannara Biotech Long-Term Debt Historical Data

The historical data trend for Cannara Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Long-Term Debt Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Long-Term Debt

Get a 7-Day Free Trial

11.98

20.15

46.19

39.64

38.45

Cannara Biotech Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Long-Term Debt	Get a 7-Day Free Trial															39.41	5.13	38.95	38.45	32.68

Cannara Biotech (TSXV:LOVE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Cannara Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Nicholas Sosiak	Senior Officer
Donald John Olds	Director
Olymbec Investments Inc.	10% Security Holder
Derek Elan Stern	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder